AGCT1531
Open to Accrual
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Principal Investigator
Status
Open to Accrual
Date Opened To Accrual
May 8, 2017
Disease Site
Gynecologic [GY] Other
Phase
III
Developmental Therapeutics
No
Primary Objective
All information for this Intergroup study is available on the CTSU menu. Please enroll your eligible patients to this important trial. Enrollment credited to NRG Oncology will count towards membership requirements.
Patient Population
X
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
